Obsessive–Compulsive Disorder (OCD) is a chronic psychiatric condition with a lifetime prevalence of 2–3%. It significantly burdens quality of life and is associated with substantial economic and disease burdens. Cognitive-behavioral therapy and high-dose selective serotonin reuptake inhibitors are considered the first-line treatments for OCD. Approximately two-thirds of patients with Obsessive–Compulsive Disorder (OCD) exhibit inadequate responses to current standard therapies, thus lacking adequate therapy, resulting in a loss of quality of life and huge economic burdens. Repetitive transcranial stimulation (rTMS) is a non-invasive, safe, and well-tolerated intervention that modulates prefrontal cortical circuits involved in OCD. A previous systematic review explored the therapeutic effects of rTMS applied to the dorsolateral prefrontal cortex (dlPFC) area in patients with treatment-resistant OCD. It showed that the application of high-frequency and low-frequency (LF) rTMS to the dlPFC region yielded controversial post-treatment Y-BOCS (Yale-Brown Obsessive–Compulsive Scale) findings due to factors such as small sample sizes, short-term study durations, and variations in rTMS protocols. Objectives: Thus, we propose a theoretical protocol based on previous findings to assess better the effect of LF rTMS for treatment-resistant OCD patients. Methods: We will recruit patients with moderate to severe OCD and limited response to previous treatments from in- and outpatient clinics. We will use fMRI for precious localization of the right dlPFC and application of 1 Hz stimulation of in total 2000 pulses with three times 40 s inter-train intervals 5 days a week, in 6 consecutive weeks. The primary outcome will be the mean reduction in Y-BOCS at the end of this study. Conclusions: This study highlights rTMS’s potential to reform OCD treatment, accentuate safety, accessibility, clinical integration, and future research foundations.
21 October 2026 in Tremor and Other Hyperkinetic Movements
Background: Parakinesia brachialis oscitans (PBO) is a rarely reported phenomenon in which a paretic limb moves involuntarily during yawning. The literature consists predominantly of case reports and small series, with limited comparative evidence. Methods: We conducted a PRISMA-ScR-guided scoping review of PubMed, Embase, and Web of Science from inception to 28 August 2026, with backward citation searching. Eligible reports described one or more patients with an involuntary, stereotyped, yawn-locked movement of a paretic limb after a focal central nervous system lesion, with the lesion site reported on neuroimaging. Data included demographics, movement description, latency, lesion site, etiology, and outcome. Results: Twenty-two reports describing 31 patients met the inclusion criteria. Most patients were men (67.7%), with a mean age of 56.1 years. PBO involved the upper limb alone in 29 patients (93.5%). Acute ischemic stroke was the most common etiology (83.9%). Lesions were often seen in the internal capsule (44.4%) and the corona radiata or subcortical white matter (40.7%). Onset ranged from immediate to four months after the lesion. Complete resolution was documented in 10 patients (32.3%), PBO persisted for up to three years in five, and outcome was not reported in 15 (48.4%). Discussion: PBO is associated with focal lesions affecting distributed voluntary motor-control networks, frequently involving subcortical motor pathways. Although no mechanism has been established, the observations suggest a release of preserved brainstem and extrapyramidal circuits. Outcome was unreported in almost half the cases; prospective, standardized reporting is needed to clarify its course and prognostic significance. Highlights This scoping review gathered 22 reports describing 31 patients with PBO after a focal brain injury. PBO involved the upper limb alone in 29 patients and lesions were most commonly subcortical, involving the internal capsule. Onset ranged from presentation to four months and PBO persisted for up to three years. However, the outcome was not reported in half of the included cases.
1 January 2021 in Revista Ecuatoriana de Neurologia
Estimada editora: Ha transcurrido un año desde el inicio de la pandemia por COVID-19 y junto a esta las medidas de distanciamiento social. Durante este tiempo, la educación médica ha sufrido cambios relevantes incluyendo el uso de videoconferencias para impartir clases y la suspensión indefinida de prácticas intrahospitalarias. No obstante, me preocupa el impacto que estos cambios puedan tener en nosotros como futuros médicos.
8 October 2026 in American Journal of Physical Medicine & Rehabilitation
Objectives: To determine the association between Multiple Sclerosis (MS) and Degenerative Spine Disease (DSD) and the subsequent utilization of interventional pain (IVP) procedures and spine surgery. Design: A retrospective, active comparator cohort study using TriNetX. Adults with MS were matched to adults with migraine without aura. The primary outcome was the incidence of newly recorded composite DSD within a 5-year analysis window. Utilization of spine surgery and IVP procedures was assessed over a 1-year period in separately matched cohorts indexed at the time of incident DSD. Results: Among 288,401 matched patients per cohort, composite DSD occurred in 12.7% of patients with MS and 9.3% of comparators (risk ratio, 1.36). Cervical/thoracic DSD diagnoses were more frequent in MS, while lumbar cases were slightly less common. Spine surgery rates were lower in MS (1.9% vs. 2.4%; risk ratio, 0.82), as were interventional pain procedures (3.2% vs. 5.1%; risk ratio, 0.63). Conclusions: MS was associated with more frequent recorded DSD, with variation by anatomic region. IVP procedures were recorded less often among patients with MS, whereas evidence for lower overall spine surgery utilization varied across analyses.